Agilent Technologies, Inc. $A Shares Purchased by Lido Advisors LLC

Posted by Geri Gentry on Jul 27th, 2026

Lido Advisors LLC increased its position in shares of Agilent Technologies, Inc. (NYSE:A – Free Report) by 46.8% during the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 22,200 shares of the medical research company’s stock after buying an additional 7,075 shares during the period. Lido Advisors LLC’s holdings in Agilent Technologies were worth $2,536,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in A. Mitsubishi UFJ Asset Management Co. Ltd. raised its holdings in Agilent Technologies by 4.3% in the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 599,581 shares of the medical research company’s stock worth $82,712,000 after purchasing an additional 24,687 shares during the period. Massachusetts Financial Services Co. MA grew its holdings in Agilent Technologies by 13.8% in the fourth quarter. Massachusetts Financial Services Co. MA now owns 14,147,601 shares of the medical research company’s stock valued at $1,925,064,000 after purchasing an additional 1,713,216 shares during the period. CCLA Investment Management grew its holdings in Agilent Technologies by 1.9% in the fourth quarter. CCLA Investment Management now owns 1,047,488 shares of the medical research company’s stock valued at $142,542,000 after purchasing an additional 19,518 shares during the period. Mirae Asset Global Investments Co. Ltd. increased its position in shares of Agilent Technologies by 20.9% in the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 53,422 shares of the medical research company’s stock valued at $7,269,000 after buying an additional 9,236 shares in the last quarter. Finally, Crossmark Global Holdings Inc. increased its position in shares of Agilent Technologies by 39.6% in the fourth quarter. Crossmark Global Holdings Inc. now owns 33,918 shares of the medical research company’s stock valued at $4,615,000 after buying an additional 9,615 shares in the last quarter.

Agilent Technologies Trading Up 0.1%

A opened at $138.65 on Monday. The firm has a market capitalization of $39.16 billion, a price-to-earnings ratio of 27.84, a price-to-earnings-growth ratio of 2.46 and a beta of 1.25. The company’s 50 day simple moving average is $129.75 and its two-hundred day simple moving average is $125.43. Agilent Technologies, Inc. has a 1-year low of $108.35 and a 1-year high of $160.27. The company has a debt-to-equity ratio of 0.43, a current ratio of 2.10 and a quick ratio of 1.62.

Agilent Technologies (NYSE:A – Get Free Report) last posted its quarterly earnings results on Wednesday, May 27th. The medical research company reported $1.49 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.41 by $0.08. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.The business had revenue of $1.83 billion during the quarter, compared to analyst estimates of $1.80 billion. During the same period in the prior year, the business earned $1.31 earnings per share. The business’s revenue was up 10.0% compared to the same quarter last year. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. Analysts expect that Agilent Technologies, Inc. will post 6.01 EPS for the current fiscal year.

Agilent Technologies Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Wednesday, July 22nd. Shareholders of record on Tuesday, June 30th were issued a $0.255 dividend. This represents a $1.02 annualized dividend and a yield of 0.7%. The ex-dividend date was Tuesday, June 30th. Agilent Technologies’s dividend payout ratio is presently 20.48%.

Analyst Upgrades and Downgrades

A has been the topic of a number of recent analyst reports. Jefferies Financial Group began coverage on Agilent Technologies in a research report on Thursday, July 9th. They set a “hold” rating and a $135.00 target price on the stock. Weiss Ratings raised shares of Agilent Technologies from a “hold (c-)” rating to a “hold (c)” rating in a report on Tuesday, June 2nd. Piper Sandler began coverage on shares of Agilent Technologies in a report on Thursday, June 11th. They set a “neutral” rating and a $150.00 price objective on the stock. Robert W. Baird lifted their target price on shares of Agilent Technologies from $155.00 to $156.00 and gave the company an “outperform” rating in a research report on Tuesday, May 26th. Finally, Wolfe Research reissued a “hold” rating on shares of Agilent Technologies in a research note on Tuesday, June 2nd. Two investment analysts have rated the stock with a Strong Buy rating, thirteen have given a Buy rating and four have given a Hold rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $159.35.

Get Our Latest Stock Report on Agilent Technologies

Agilent Technologies Company Profile

(Free Report)

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.